By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


XBiotech USA, Inc. 

8201 E Riverside Drive
Building 4, Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-386-5107 Fax: n/a


Start Up

Company News
Xbiotech Announces Agreement With The NCIC Clinical Trials Group To Collaborate On Phase II Study In Non-Small Cell Lung Cancer (NSCLC) 12/11/2015 7:11:42 AM
Xbiotech Announces Positive Results In European Phase III Study For Its Breakthrough Therapy For Colorectal Cancer 12/7/2015 7:44:27 AM
Xbiotech Added To The MSCI US Small Cap 1750 And The MSCI Investable Market 2500 Indexes 11/20/2015 7:58:12 AM
XBiotech Provides Third Quarter 2015 Corporate And Clinical Update 11/12/2015 8:15:34 AM
Xbiotech Identifies Positive Donors For Anti-Clostridium Difficile Therapeutic Antibody Only Two Weeks After Initial Screening 11/11/2015 7:21:12 AM
Xbiotech Announces Positive Results For Its Anti-Ebola Therapeutic Candidates Following Evaluation By USAMRIID 11/9/2015 7:40:17 AM
XBiotech To Provide Third Quarter Business Update 11/5/2015 10:06:03 AM
XBiotech Initiates Program To Develop Antibody Against Clostridium Difficile 10/26/2015 7:23:54 AM
XBiotech Strengthens Intellectual Property Portfolio For Its True Human Antibody Technology 10/19/2015 8:16:25 AM
XBiotech USA (XBIT) Announces Publication Of Clinical Results Supporting The Potential Of Its True Human(TM) Antibody As A Cardiovascular Therapy 10/2/2015 7:30:58 AM